M. Gander

Sequential administration of temozolomide and fotemustine: depletion of O6-alkyl guanine-DNA transferase in blood lymphocytes and in tumours.

J. Biollaz, L. Perey, C. Marzolini, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Pharmacokinetics of temozolomide in association with fotemustine in malignant melanoma and malignant glioma patients: comparison of oral, intravenous, and hepatic intra-arterial administration

T. Buclin, J. Biollaz, C. Marzolini, 1998, Cancer Chemotherapy and Pharmacology.

Determination of temozolomide in human plasma and urine by high-performance liquid chromatography after solid-phase extraction.

J. Biollaz, L. Decosterd, S. Leyvraz, 1995, Journal of chromatography. B, Biomedical applications.

Intracellular localization and intercellular heterogeneity of the human DNA repair protein O6-methylguanine-DNA methyltransferase

M. Citron, M. Dolan, D. Yarosh, 1996, Cancer Chemotherapy and Pharmacology.

For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Review Temozolomide for Brain Tumours Current and Future Developments in the Use of Temozolomide for the Treatment of Brain Tumours

R. Stupp, S. Leyvraz, E. Newlands, 2022 .

A rare case of prednimustine-induced myoclonus.

S. Leyvraz, C. Monnerat, M. Gander, 1997, Journal of the National Cancer Institute.

Measurement of DNA cross-linking in patients on ifosfamide therapy using the single cell gel electrophoresis (comet) assay.

R. Souhami, V. Spanswick, J. Hartley, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.